Timothy Hoey
Chief Tech/Sci/R&D Officer bij TENAYA THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Dr. Timothy Hoey is a Chief Scientific Officer at Tenaya Therapeutics, Inc. Dr. Hoey was previously employed as a Co-Chief Scientific Officer & SVP-Cancer Biology by OncoMed Pharmaceuticals, Inc., a Director-Biology Department by Amgen, Inc., and a Director-Biology Department by Tularik, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from The Trustees of Columbia University in The City of New York.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-03-2024 | 245 346 ( 0.31% ) | 1 M $ | 31-03-2024 |
Actieve functies van Timothy Hoey
| Bedrijven | Functie | Begin |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-08-2017 |
Eerdere bekende functies van Timothy Hoey
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01-01-2017 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director/Board Member | 14-12-2011 |
Opleiding van Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
